CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Agios Pharmaceuticals Inc. (AGIO) on Wednesday reported a loss of $99.1 million in its first quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.69.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.81 per share.
The biopharmaceutical company posted revenue of $20.7 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $13.8 million.
Agios Pharmaceuticals shares have fallen nearly 9% since the beginning of the year. The stock has fallen 16% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO